Aptevo Therapeutics Inc. Logo

Aptevo Therapeutics Inc.

Clinical-stage biotech developing antibody-based immunotherapies for cancer.

APVO | US

Overview

Corporate Details

ISIN(s):
US03835L2079
LEI:
Country:
United States of America
Address:
2401 4TH AVE., 98121 SEATTLE

Description

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The company specializes in creating bispecific and trispecific antibody-based therapeutics designed to harness a patient's immune system to fight malignancies. Its pipeline includes multiple candidates targeting both hematologic cancers and solid tumors. The lead candidate, Mipletamig, is a CD3 T-cell engager targeting the CD123 tumor antigen for the treatment of Acute Myeloid Leukemia (AML). Other programs in development target various tumor antigens, including PSMA for prostate cancer and Nectin-4 for solid tumors, utilizing mechanisms like T-cell engagement and co-stimulation to enhance anti-tumor activity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Aptevo Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aptevo Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aptevo Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GeneOne Life Science, Inc. Logo
Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.
South Korea
011000
Geneuro Logo
Develops therapies for neurological and autoimmune diseases by targeting HERVs.
Switzerland
GEM
GENFIT Logo
Develops therapies and diagnostics for patients with rare and severe liver diseases.
France
GNFT
GENFLOW BIOSCIENCES PLC Logo
A biotechnology company developing gene therapies that target the aging process.
United Kingdom
GENF
GENINCODE PLC Logo
Specializes in genetic risk assessment and prediction of cardiovascular disease.
United Kingdom
GENI
GENINUS Inc. Logo
A biotech company offering genomic analysis for precision medicine and drug development.
South Korea
389030
Genomed Spolka Akcyjna Logo
Biotechnology firm for genetic research and molecular diagnostics using NGS technology.
Poland
GEN
A molecular diagnostics company developing tests for the early detection of cancer.
South Korea
228760
Genomic Vision Logo
Provides DNA analysis and quality control for bioproduction and gene therapy.
France
GV
genOway Logo
Designs and develops genetically modified preclinical models for research.
France
ALGEN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.